Stephen Stefani
Overview
Explore the profile of Stephen Stefani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
325
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Landeiro L, Martins T, Grigolon R, Monteiro I, Balardin J, Padilha E, et al.
Front Pharmacol
. 2024 Sep;
15:1338546.
PMID: 39224777
Introduction: Breast cancer (BC) is one of the leading causes of cancer and is the first cause of death from malignant tumors among women worldwide. New cancer therapies receive regulatory...
2.
3.
Mateo J, Steuten L, Aftimos P, Andre F, Davies M, Garralda E, et al.
Nat Med
. 2022 Apr;
28(4):658-665.
PMID: 35440717
With the increasing use of genomic profiling for diagnosis and therapy guidance in many tumor types, precision oncology is rapidly reshaping cancer care. However, the current trajectory of drug development...
4.
Buehler A, Castilho G, Dionne P, Stefani S
Ther Adv Med Oncol
. 2021 May;
13:17588359211000593.
PMID: 33948121
Background: The global burden of breast cancer (BC) is high, especially in advanced stages. CDK 4/6 inhibitors represent a paradigm shift in the treatment of advanced BC HR+/HER2-, given the...
5.
Santos M, Stefani S, Neto J, Santos M
Value Health Reg Issues
. 2019 Jan;
20:12-18.
PMID: 30634086
The congress of the International Society for Pharmacoeconomics and Outcomes Research is one of the main worldwide forums for the dissemination of research and knowledge on healthcare economics. Brazil is...
6.
Santos M, Coudry R, Ferreira C, Stefani S, Cunha I, Zalis M, et al.
Lancet Oncol
. 2019 Jan;
20(1):20-23.
PMID: 30614460
No abstract available.
7.
Ferreira C, Nicolini A, Dalurzo L, Stefani S, Teich V, Leighl N
Curr Drug Targets
. 2018 Sep;
20(1):81-86.
PMID: 30207218
The development of therapies that restore or activate the host immune response - the socalled "immuno-oncologic" therapy - has improved the survival of some cancer patients harboring specific tumor types....
8.
Goss P, Lee B, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, et al.
Lancet Oncol
. 2013 May;
14(5):391-436.
PMID: 23628188
Non-communicable diseases, including cancer, are overtaking infectious disease as the leading health-care threat in middle-income and low-income countries. Latin American and Caribbean countries are struggling to respond to increasing morbidity...
9.
Araujo G, Caporale J, Stefani S, Pinto D, Caso A
Value Health
. 2011 Aug;
14(5 Suppl 1):S8-12.
PMID: 21839905
No abstract available.
10.
Toney P, Hilgerson A, Stefani S, Mandi D
Clin Podiatr Med Surg
. 2006 Oct;
23(4):777-81, viii.
PMID: 17067895
Propofol is a common drug used for anesthetic induction of patients undergoing surgery. This popular drug has been around for many years and has been subjected to changes in formulation...